Publication date: Nov 25, 2024
The COVID-19 pandemic significantly threatens immunocompromised patients. We aimed to investigate the clinical and paraclinical findings and consequences of COVID-19 in kidney transplantation recipients. In this retrospective study, kidney transplant recipients admitted to Ayatollah Rouhani, Shahid Beheshti, and Shahid Yahyanejad referral hospitals of Babol, North of Iran, with a diagnosis of COVID-19, were examined. Information such as demographic and laboratory findings, clinical symptoms, and treatments received was entered into pre-prepared questionnaires. Out of the 35 patients included in the study, 19 (54. 3%) were males, and 16 (45. 7%) were females. The mean age of patients was 47. 46 +/- 11. 28. Among the clinical symptoms, cough and decreased level of consciousness were associated with a higher mortality rate (P= 0. 02). Furthermore, the mortality rate was found to be 17. 1%. C-reactive protein (CRP) level, oxygen saturation percentage, and diffuse lung involvement were significantly associated with COVID-19 mortality (p
Concepts | Keywords |
---|---|
Immunocompromised | COVID-19 |
Iran | COVID-19 mortality |
Kidney | COVID-19 therapy |
Retrospective | Kidney transplantation |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | COVID-19 |
disease | MESH | infection |
disease | MESH | immunocompromised patients |
drug | DRUGBANK | Oxygen |
disease | MESH | Long Covid |